Spencer Osborne
Contributor since: 2007
Company: SiriusBuzz Premium
Latest Articles
MannKind: Afrezza Scripts Pop Above 600 Whilst Company Awaits Partnership Approval
Youngevity Could Be The Most Undervalued And Safest CBD Play On The Market
MannKind: Afrezza Sales Close Out Q3 Modestly
With No Deal Inked Yet On ADHD Drug, KemPharm Announces Public Offering
MannKind Is A Better R&D Company Than A Full Service Pharma Company
MannKind - Afrezza Scripts Pass 600 As Company Awaits FTC Approval Of United Therapeutics Deal
MannKind Moves Debt Payment By One Month - Dilutes 5.7 Million Shares
Arena Posts Positive Phase 2 Results For Crohn's Disease* Candidate - What Investors Should Consider
Sirius XM And Pandora Can Take Synergies Quite Far
Youngevity Seeking To Enter CBD Market, While Its Coffee Business Continues To Grow
Sirius XM To Buy Pandora In A $3.5 Billion Mega-Deal
MannKind - Afrezza Scripts Getting To Crunch Time On Meeting Guidance
Sirius XM To Get Stability In Royalty Rates - Should Offer Stability In Stock
United Therapeutics Inks Deal With Samumed. What Investors Need To Consider
KemPharm Announces Positive Data - Street Wants To See A Partner
MannKind - Afrezza Scripts Need Better Trajectory
Why MannKind Warrants Are Important
MannKind: Afrezza Scripts Close Out August Below 600 - Growth Needed
Liquida Gets Passed Over On Inhaled Treprostonil
MannKind And United Therapeutics Ink Deal For PAH Drug - What Investors Need To Know
MannKind - Script Growth Slow As Debt Payment Is Due
MannKind - Afrezza Scripts Dip At Inopportune Time
MannKind - Afrezza Scripts Still In 500s As Cash Balance Dwindles Down
Pandora And Live Nation Ink Deal With T-Mobile - What Investors Should Know
Youngevity Q2 Showing Growth In All The Right Places
Liquidia: Is It Worth Getting On Board Early?
MannKind - Afrezza Scripts Dip As Cash Crunch Continues
KemPharm Reports Q2 Earnings - Financials Are Secondary To Binary Events
United Therapeutics Releases Positive Data On PAH Drug - What Investors Should Know.
Arena Reports Loss As Expected - Pipeline Will Drive The Stock
Wynn Resorts Settles With Elaine Wynn
Assessing MannKind As Stock Price Approaches $1 Per Share